Kodak Expands Pharmaceuticals Portfolio With Four Regulated Products
January 26, 2026
January 26, 2026
ROCHESTER, New York, Jan. 26 -- Kodak issued the following news release:
* * *
Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products
New U.S.-Manufactured PBS and WFI Offerings Deliver Reliable, High-Quality Supply for Labs, Biopharma Industry and CDMOs
*
Eastman Kodak Company (NYSE: KODK) today announced the expansion of its pharmaceuticals portfolio with four new regulated products: KODAK Phosphate Buffered Saline . . .
* * *
Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products
New U.S.-Manufactured PBS and WFI Offerings Deliver Reliable, High-Quality Supply for Labs, Biopharma Industry and CDMOs
*
Eastman Kodak Company (NYSE: KODK) today announced the expansion of its pharmaceuticals portfolio with four new regulated products: KODAK Phosphate Buffered Saline . . .